These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20211311)

  • 1. Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention.
    Schenkeveld L; Pedersen SS; van Nierop JW; Lenzen MJ; de Jaegere PP; Serruys PW; van Domburg RT
    Am Heart J; 2010 Mar; 159(3):471-6. PubMed ID: 20211311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired health status in Type D patients following PCI in the drug-eluting stent era.
    Pedersen SS; Denollet J; Ong AT; Serruys PW; Erdman RA; van Domburg RT
    Int J Cardiol; 2007 Jan; 114(3):358-65. PubMed ID: 16753232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for impaired health status differ in women and men treated with percutaneous coronary intervention in the drug-eluting stent era.
    Pedersen SS; Ong AT; Lemos PA; Erdman RA; Serruys PW; van Domburg RT
    J Psychosom Res; 2006 Jul; 61(1):11-7. PubMed ID: 16813840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in health-related quality of life following percutaneous coronary intervention: a longitudinal study.
    Wong MS; Chair SY
    Int J Nurs Stud; 2007 Nov; 44(8):1334-42. PubMed ID: 16982057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up.
    Szygula-Jurkiewicz B; Zembala M; Wilczek K; Wojnicz R; Polonski L
    Eur J Cardiothorac Surg; 2005 May; 27(5):882-6. PubMed ID: 15848330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention.
    Pedersen SS; Denollet J; Spindler H; Ong AT; Serruys PW; Erdman RA; van Domburg RT
    J Psychosom Res; 2006 Dec; 61(6):783-9. PubMed ID: 17141666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial.
    Zhang Z; Mahoney EM; Stables RH; Booth J; Nugara F; Spertus JA; Weintraub WS
    Circulation; 2003 Oct; 108(14):1694-700. PubMed ID: 12975252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
    Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004.
    Blackledge HM; Squire IB
    Heart; 2009 Feb; 95(4):304-11. PubMed ID: 19001000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative cardiac risk index predicts long-term mortality and health status.
    Hoeks SE; op Reimer WJ; van Gestel YR; Smolderen KG; Verhagen H; van Domburg RT; van Urk H; Poldermans D
    Am J Med; 2009 Jun; 122(6):559-65. PubMed ID: 19376487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts.
    Mehta RH; Honeycutt E; Shaw LK; Glower D; Harrington RA; Sketch MH
    Am Heart J; 2006 Oct; 152(4):801-6. PubMed ID: 16996861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: a randomized trial in nonemergent patients.
    Melberg T; Nordrehaug JE; Nilsen DW
    Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):235-43. PubMed ID: 20150814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease.
    Migliorini A; Valenti R; Marcucci R; Parodi G; Giuliani G; Buonamici P; Cerisano G; Carrabba N; Gensini GF; Abbate R; Antoniucci D
    Circulation; 2009 Dec; 120(22):2214-21. PubMed ID: 19917884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.